Related Experiment Video
Updated: Aug 16, 2025

Growth of Mycobacterium tuberculosis Biofilms
Published on: February 15, 2012
Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger
Elena G Salina1, Vadim Makarov1
1Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia.
Understanding dormant tuberculosis (TB) bacilli is key to fighting latent TB infections. Research is needed to find ways to target these dormant mycobacteria for better diagnosis and treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Immunology
Background:
- Tuberculosis (TB) infections involve both active and dormant Mycobacterium tuberculosis populations.
- Dormant bacilli exhibit reduced metabolic activity, complicating TB diagnosis and treatment.
- Current diagnostics often overlook dormant bacilli, limiting the effectiveness against latent TB.
Purpose of the Study:
- To highlight the critical role of dormant Mycobacterium tuberculosis in latent TB.
- To emphasize the need for novel strategies targeting dormant bacilli.
- To underscore the importance of studying dormancy and resuscitation mechanisms.
Main Methods:
- Review of existing literature on TB pathogenesis and dormancy.
- Analysis of diagnostic challenges in latent TB.
- Proposal for future research directions using in vitro and in vivo models.
Main Results:
- Latent TB is characterized by dormant bacilli that are tolerant to drugs.
- Active TB can develop from latent infection through bacilli resuscitation.
- Existing diagnostic tools inadequately address the dormant bacterial population.
Conclusions:
- Targeting dormant Mycobacterium tuberculosis is essential for eradicating latent TB.
- Further research into dormancy and resuscitation mechanisms is crucial.
- Understanding these processes can improve TB control, patient outcomes, and prevent transmission.
More Related Videos
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...